Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
News Pharma outlines roadmap as UN takes on superbug fight UN leaders meet amid warnings over drug resistant bacteria.
News Sobi adds rare lymphoma drug with $580m Innate tie-up Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
